Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 9.73B 1.44B 1.25B 1.16B 1.09B 2.04B 136B 2.05B 13.76B 5.34B 66.87B 5.4B 5.29B 232B P/E 2026 *
14.5x
P/E 2027 * 12x
Enterprise Value 9.73B 1.44B 1.25B 1.16B 1.09B 2.04B 136B 2.05B 13.76B 5.34B 66.87B 5.4B 5.29B 232B EV / Sales 2026 *
2.25x
EV / Sales 2027 * 2.05x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day-1.22%
1 week-3.17%
Current month-6.66%
1 month-9.13%
3 months-13.09%
6 months-24.08%
Current year-19.36%
1 week 22.45
Extreme 22.45
23.87
1 month 22.45
Extreme 22.45
24.98
Current year 22.45
Extreme 22.45
29.22
1 year 22.45
Extreme 22.45
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.54
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 27/05/2019
Director of Finance/CFO 49 27/12/2023
Corporate Officer/Principal 40 18/08/2021
Director TitleAgeSince
Chairman 64 15/03/2010
Director/Board Member 48 27/05/2019
Director/Board Member 40 13/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%-3.17%-19.41%-19.73% 1.44B
-1.21%-5.37%+39.94%+145.38% 980B
-2.48%-4.17%+51.52%+39.07% 550B
-2.14%-3.68%+16.71%+56.15% 382B
-1.18%+0.25%+25.86%+16.53% 317B
-2.36%-3.12%+24.71%+11.59% 270B
-2.45%-2.88%+24.29%+30.06% 269B
-1.91%-0.87%-41.95%-49.25% 191B
-1.19%-4.65%+16.56%+47.00% 182B
-1.35%-1.68%+14.59%+56.94% 154B
Average -1.75%-2.94%+15.28%+33.37% 329.55B
Weighted average by Cap. -1.77%-3.38%+28.06%+63.64%

Financials

2026 *2027 *
Net sales 4.32B 639M 557M 513M 483M 903M 60.2B 909M 6.1B 2.37B 29.67B 2.4B 2.35B 103B 4.75B 703M 613M 565M 531M 994M 66.28B 1B 6.72B 2.61B 32.66B 2.64B 2.58B 113B
Net income 674M 99.7M 86.87M 80.08M 75.32M 141M 9.4B 142M 953M 370M 4.63B 374M 366M 16.05B 745M 110M 96.02M 88.52M 83.26M 156M 10.39B 157M 1.05B 409M 5.12B 414M 405M 17.74B
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
18/06/26 22.58 ¥ -1.22% 4,953,980
17/06/26 22.86 ¥ -1.76% 3,908,181
16/06/26 23.27 ¥ -1.27% 4,329,430
15/06/26 23.57 ¥ -1.09% 5,509,428
12/06/26 23.83 ¥ +2.19% 4,728,634
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.58CNY
Average target price
36.25CNY
Spread / Average Target
+60.54%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!